| | | | |

Surgery May Impact Mesothelioma Survival More Than Stage

2214038_patient5A study conducted in Belgium appears to support the idea that whether or not a malignant pleural mesothelioma patient undergoes surgery may be a better predictor of survival than the stage of their cancer.

The study including 101 patients diagnosed with or treated for pleural mesothelioma between 2001 and 2015 at Antwerp University Hospital.

The goal of the study was to determine how closely the experience with mesothelioma at this single institution matched that of other institutions as documented in the medical literature.

Overall Mesothelioma Survival

In most respects, the mesothelioma survival data from the Antwerp study was similar to past mesothelioma studies. The analysis found that most (80%) mesothelioma patients at their hospital were men and that their median age was 66. More than 80 percent had the epithelioid type of mesothelioma, which is also consistent with rates around the world.

Overall, the pleural mesothelioma patients in the study had a median survival of 18.3 months. At one year, 68 percent of patients were still living. By year two, 37 percent were still alive. Only 7 percent of the mesothelioma patients survived for five years or more.

Mesothelioma Staging System “Limited”

Notably, the researchers found no significant survival difference between patients in the several top TNM cancer staging categories, suggesting that stage alone may not give a clear prognostic picture. Instead, surgery seemed to have a bigger impact on mesothelioma survival.

“A significant difference in survival was observed in patients undergoing surgery versus no surgery…and treatment with chemotherapy alone versus chemotherapy with surgery,” reports study author Andreas Domen with the Department of Thoracic and Vascular Surgery at Antwerp University Hospital.

Understanding the TNM Staging System

TNM staging is a method for predicting outcomes and selecting mesothelioma treatment options based on three factors – the size of the original tumor (T), the level of lymph node (N) involvement, and metastasis (M) or spread of the cancer. TNM is developed and maintained by the Union for International Cancer Control as a way to standardize cancer classification across the globe.

The other factors with the biggest impact on mesothelioma outcomes in the Antwerp study were smoking and histological subtype. Smokers tended to have worse outcomes as did patients with non-epithelioid (sarcomatoid or biphasic) mesothelioma.

“Descriptive and survival analysis of our patient database confirmed the limitations of the current staging system and were concordant with literature regarding malignant pleural mesothelioma,” concludes the report in the Belgian journal Acta Chirugica Belgica.

Source:

Domen, A, et al, “Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year period”, June 2017, Acta Chirugica Belgica, pp. 157-163

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…